{"name":"Zenith Epigenetics","slug":"zenith-epigenetics","ticker":"","exchange":"","domain":"zenithepigenetics.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxNYjF5N2lVbjNNdlgxT2R3ZzZ1SVBlMnpyX1pnZUswLUVMRGRZMEt4Y0NJS2ZJX3dRRmZXSW9mMGp2UzljczN6UEdxQ0NGYTR2bVYydkQ5SzVxLUtfNmFhWG9vQlhER2ZDRXYyaHJZZFdTQmtZZWpSdGdOc3dtYVdyMUh1d2UydFB2WkdQeG5oeDZrb1ZEb0hOLWdacVZfeDZjbmE1OW1pMkp0OU13M05abHVfUUI5SmZJdV9uaTNwV2RCeURoSk1ScU5UVU9JZVZFWnlNUFc2ekJHN3ZaaHZFZlF5a21iZ3RyYkE2bTVwVmZIVGZPUDNZYUVvang?oc=5","date":"2026-02-11","type":"regulatory","source":"The Malaysian Reserve","summary":"PROTAC Market Shows Accelerated Growth During the Forecast Period (2025-2034) Amid Rising Targeted Therapy Demand | DelveInsight - The Malaysian Reserve","headline":"PROTAC Market Shows Accelerated Growth During the Forecast Period (2025-2034) Amid Rising Targeted Therapy Demand | Delv","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxOaWJHTkVvd3diWm9pX3c0aEx4MnZfMmRmRkczT3g4ZkE1RmE4eU1Qd1JmSXBsVThCYUlib0dLNEt1M0tVOHlZNnBodFpuRngxM2kyOFBkOUlENlB6bUx4Q2NqUmY4ek02SmtlT1h6ZUQ0M29nYzJtVkNUTC01aEpyUkN5VXBSV3U4aDczQ0NqMVFWRjcwTHd4ejdFT3ZLTjNtaWdhT3pKNkYtWlY1REJaUEk0VWN4UjdLaWg5NFhtbkhqUXJCekhoWnB1RG5FTFRpOEttc1RwLVY1VGdQSlB6M2hlcC1KTENhSC01WWRtNXh4NnVCNDN3YkJTZURpOTg?oc=5","date":"2026-01-20","type":"pipeline","source":"PR Newswire","summary":"PSMA-Targeted Therapy Market Set to Expand by 2034 on Strong Pipeline and Increasing Diagnosis Rates | DelveInsight - PR Newswire","headline":"PSMA-Targeted Therapy Market Set to Expand by 2034 on Strong Pipeline and Increasing Diagnosis Rates | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AJBVV95cUxPcG02MzkwN3FNRFZGZnFTVEZWUXpIaUtiYVBNMlFkVEVOLS1OTVhhcWVUM284VkR1T0FNQkNWM2hxWE9HUXlmX1ZUTTBsRWZpOFlGVVExT19vMy0tX2hPRXRaX3FoMEQ5MFR5MEx2TVBIYV9DeUw1Q21FVzBYcWpNdXFMRkZtTWxuNjl3ZlE4VEZhYklIV295alFMeml3RzF4WlEzX0RkdHNTdkV3eG9sUGFUYjVtenlIR1VnV1RCQ293blNONVhnUGRBY3c4bFpsdW5WZzFWeEdoM0QxN2gwZmxnTmRkanBmU2VZNE43cVRveDlWVW5hekNnV3NvZWpjbnlxYjFYRVh4dkpWLVFHeU9sNEZkdVJ5eUZWRWF6TFhqV3N4a054V3VnZEY1aGx2UmFwVEpkZEZoVy1QNklnWVo2X2hCc2lydjhYVHotS0VyT3I0ZVgwcnRkaUg0dGxZ?oc=5","date":"2026-01-05","type":"regulatory","source":"PR Newswire UK","summary":"Castration-sensitive Prostate Cancer Market Projected to Grow at a 13.2% CAGR (2020-2034), Driven by Expanded Approval and Wider Commercialization Opportunity in nmCSPC Segment | DelveInsight - PR New","headline":"Castration-sensitive Prostate Cancer Market Projected to Grow at a 13.2% CAGR (2020-2034), Driven by Expanded Approval a","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxPUF9EOThOU2lobE44Z2w1SFBVaUdYWEV0WVhPLVZOZXV4VERPclVlSWhSS2Z3WHZzMFpUaW9VaWYyWGF1V3I5cWtyY0xsR29hVkRNbURySTJVamNBSjhudUdTMUh3WThCeFZ2dFdtbkFvTXJFZ0NoQmxBMDVOWXNTaU1uYlFrdw?oc=5","date":"2025-11-06","type":"pipeline","source":"Pharmaceutical Technology","summary":"Cencora to invest $1bn in US pharma distribution network - Pharmaceutical Technology","headline":"Cencora to invest $1bn in US pharma distribution network","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAJBVV95cUxOc0VPcXJsc2I4Sl9mRy1DcGpqMTcwaVgxSEw2TnRVSjVjNjRFeUZwSTRheTk3UW1oWjhJUUFLc3BncTRULTN1cVpiWlN4OUFKWUFjUk9ydG9GWXRLRi10bHhpX0JOeVJpaEFhYjc1aGtJNGRCdnNpZUxvTDlOUUp6ZUxwNW92Y0VFbkVYbnFRNHU1eXZ0VU9oSUI1bFlnMWJsSkZMNHFoejQxRVRiMDlWR2hrYXNqQWEzRTJtQWYyUDVZQ1NtMHZBb0xuNG9NbE1pVnhnbjN5MXNOWktFRTRSbVZRWVYxOVBLRE5KeUpudzcyN3RxRTF3bWpTWmRjM0lvQ2JCUmVBSEU0ZUVhaTd6UWRidGJNVDR1bXdpOGNWZGk0cVpPeWZjaFJMX3FackFU?oc=5","date":"2025-08-27","type":"pipeline","source":"PR Newswire","summary":"Androgen Receptor Targeted Therapies Market Forecast: Key Trends and Growth Projections Across the 7MM During the Forecast Period (2025-2034) | DelveInsight - PR Newswire","headline":"Androgen Receptor Targeted Therapies Market Forecast: Key Trends and Growth Projections Across the 7MM During the Foreca","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNdVljUG0ycURLelczRGx1ajNoNjNoSUY5c1Y1eUNSWkk4Yzk4NF90enZOVDI1U0R2TFNUaFNad0hlVVlKZmdkTFU0RXM5ZDRJX2FmMXFFR2lLMjg4WUhEZkgya2xjd3VJTnkwcHUzYlZjRnV6eWFGTzFwSUxxb2RkaUI3eTRkdzd4WHZMdDEtWnEtczdiWGJIZg?oc=5","date":"2025-02-17","type":"trial","source":"Yahoo Finance","summary":"Metastatic Castration-Resistant Prostate Cancer Market to Register Stupendous Growth During the Study Period (2020–2034) Owing to the Active Participation of Pharma Companies | DelveInsight - Yahoo Fi","headline":"Metastatic Castration-Resistant Prostate Cancer Market to Register Stupendous Growth During the Study Period (2020–2034)","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiwwJBVV95cUxNYWZIR1FURDU4dFFXaEs3bjFkYk4zOERRa25WempmaDRMcndkNEtQTV81NTlUWWdONjNxLVdrNmlfMHBRZVU1a055NlhFLTVQcEs0LTNFWktRZDR1RHVtVjRIMzBuMVZuUFhDa01WT3lKaTY4ckZQRjFlSnc2YzNjTjhRbU5yYjN3NC1pSU1ZYTM3b1pVRjhyVVRxMGxRbFpmcUtoQ0VDTlY3VTJySExPM0t3a1JhU3pWUGROWV9yTmNHLXZ4UUZybzdDYS05R3lwRFozaGJHTkNFVjRTV0dfb2U5VDNEODhBaDdNTmJNNl9FUzJKT29ZV016Ynk0VTZjdjQ2S3NDV3paeVpWNDFUN2IzaFpKd0RZc21mSlZwTXhxeUVnNTRuQ0hQQ0pGamZTT1M5ZjNXZ1lGdU0zbzcteXdUWQ?oc=5","date":"2024-10-15","type":"trial","source":"GlobeNewswire","summary":"Prostate Cancer Clinical Trial Pipeline Experiences - GlobeNewswire","headline":"Prostate Cancer Clinical Trial Pipeline Experiences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE1qZnRBRDVZOWJjb1pqZjNZcUlNekVoNXFVdFIxTkY3ZnUtSmZFdFF1anBRS3MtM0t3YUl2eHlibWFPTVgzcWgyVkN6ai1fdHdjcnNhVU9CbzBPYlE5aktDRnd1WktNRlBGWWRublNEbnhzRzZsV2N3TnI5VTYwVTQ?oc=5","date":"2024-04-26","type":"trial","source":"Oncology Pipeline","summary":"Bristol backs out of BET inhibition | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline","headline":"Bristol backs out of BET inhibition | ApexOnco - Clinical Trials news and analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxNUkVBNHR0OHhYVzZJSUpnNWJyYlBDVHFNU0QzUUVvbThjZVNBZmQwaFljZHNZY3k3alN3V1FKZGRxLWFPQzUyU0xhRzEybDg5ZFlMWWdDR2g0eUl4LUJPYkFzWE1wMVlhVlBHWFFlc2ZvdnpMcUpFUGY0Y1d1ZUxXVDBNU0FkaWtfZVVMdGQ2NEV1azRpbGdKVkVQZ293UWdMbWJOY2REWW1YUmJQSnlJaGkzNlV1ekhsNElObEpuVnBHQ29MeXVaYw?oc=5","date":"2022-09-08","type":"trial","source":"michiganmedicine.org","summary":"Study suggests commonly used prostate cancer treatment rewires engine of prostate tumors - michiganmedicine.org","headline":"Study suggests commonly used prostate cancer treatment rewires engine of prostate tumors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxPa01ZRlhMRmxZSnBLTmVZbkN2U0ZFR1dKNU5qYkRrQWVBSGQ1RzVvdm9BTDFTX3M2bmpxTDB5WjVkdE91VVRJVGtCNFdBSFdEVVZ1Q1JlR0R0bDg0bEUyaHV3YWZnMmpFS2Z3cUVIOTd0a09jSFNNdktqQW9VNVVFYl9lbk5FZGNiYU9kOC00bk5wdnNRTDhNaWFOSHVkMTdoY0R2WTlqY1k0QUt3Tk9vVHExdDFGRS1ha0RxYQ?oc=5","date":"2022-08-10","type":"trial","source":"The ASCO Post","summary":"Nivolumab Plus T-DXd Under Study in HER2-Expressing Metastatic Breast Cancer - The ASCO Post","headline":"Nivolumab Plus T-DXd Under Study in HER2-Expressing Metastatic Breast Cancer","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxOSVJObDg4WDl0cWNpQW9SSUc0SU9YQ05kSnJCOVZZMUUzcmVOeHVhZ2xKb0xuOHRVdVBLS25NT3g5eUtVWEFVZHJSSXYtWEVZdlFkSTE0cDFJZi1oR05jbnBQOVFIQkpQOHJoVEVZSXRqcmVHTE9ZWExybGg5YTNXc1BTM1FERkRaUVl3azlCUGJicU03SVdqQVozanZ3QUZfMFNWT1lyazE4UQ?oc=5","date":"2021-04-22","type":"pipeline","source":"Urology Times","summary":"Combo of Novel BET inhibitor and enzalutamide advances in mCRPC pipeline - Urology Times","headline":"Combo of Novel BET inhibitor and enzalutamide advances in mCRPC pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNTG5pOWVhZ1lYdzVZUnRQX2VaM1pZUzB3dkdJdEhPME5YVU80anB1Zzc4RTdhNnRXTDVlUDRJY3dvMzVGd3NzYXc0bFRMdXB2c0tvMDhYdVNraHJCdnVldXdkZ3VYcFR6RHZZSlNweUNYeWZrc3NKMTdXeGxXWUh4b25wVWxOaXp0NnFfY1VoX0VSOTJuVG9mVHhDWTVBa1BqS2RqTnBlN1d2STg?oc=5","date":"2020-05-04","type":"pipeline","source":"Zacks Small Cap Research","summary":"Zenith Epigenetics: ZEN-3694: Resistance is Futile - Zacks Small Cap Research","headline":"Zenith Epigenetics: ZEN-3694: Resistance is Futile","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}